Updated:
Philippos Asset Management
Patrick Schwarz-Schütte established the office after serving as CEO of Schwarz Pharma. The family office operates from Zug and focuses on generational wealth...
Philippos Asset Management
Patrick Schwarz-Schütte established the office after serving as CEO of Schwarz Pharma. The family office operates from Zug and focuses on generational wealth preservation through allocations to private markets. Philippos Asset Management holds LP interests in Bridgepoint Europe VI and Bridgepoint Europe V, both acquired and later sold through secondary transactions in 2021-2024. It committed to HG Mercury 4 in 2023 and exited the position via secondary sale in 2025. A direct stake in HeartBeat Labs GmbH dates to 2020. The office also maintains real estate holdings in Düsseldorf, including Dreischeibenhaus and Deiker Höfe, alongside infrastructure and hedge fund exposure. Activity centers on Europe with additional positions in the United States and Guernsey. The office lists four named principals and board members. It maintains service relationships with Ashurst for legal work and Acton Revisions AG for audit. October 2024 filings record the transfer of its Bridgepoint Europe V interest to Stepstone-managed vehicles. Adjacent structures include the Schwarz-Schütte Stiftung, which supports arts initiatives in Germany. The office structure separates investment management from operating businesses through entities such as Black Horse Investments GmbH. This setup allows direct control over real estate refurbishments and co-investments while using secondary markets for private equity liquidity management.
General information
Firm type
Single Family Office
Year founded
—
AUM
Undisclosed
Location
Region
Europe
Country
Switzerland
City
Zug
Corporate office
—
Principals
Patrick Schwarz-Schütte
Founder
Michaela Steimel
Business Partner
Christoph Schwarz-Schütte
Family Member
Martin Zita
Management Board Member
Sector focus
Frequently asked questions
Who runs investment decisions at Philippos Asset Management?
Patrick Schwarz-Schütte serves as founder. Michaela Steimel and Martin Zita hold board and management roles across the family office entities.
How does Philippos Asset Management source proprietary deal flow?
The office participates in secondary markets for private equity interests and maintains direct holdings such as HeartBeat Labs GmbH.
Does Philippos Asset Management participate in fund commitments or only direct deals?
It acts as LP in multiple private equity funds managed by Bridgepoint and Hg while also recording direct co-investments and real estate ownership.
What investment stages does Philippos Asset Management typically target?
Activity includes growth-stage and venture exposures alongside buyout fund commitments and secondary transactions.
Where does the underlying wealth come from?
The capital originates from the Schwarz Pharma business led by Patrick Schwarz-Schütte.
Does Philippos Asset Management maintain philanthropic structures?
The Schwarz-Schütte Stiftung supports cultural projects in Germany, including the Theater der Welt festival.
What is Philippos Asset Management's known posture on co-investments alongside external GPs?
It has executed direct equity positions such as the 2020 investment in HeartBeat Labs GmbH alongside fund commitments.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: